Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01446965 · ClinicalTrials.gov registry record · NA
Vest Prevention of Early Sudden Death Trial and VEST Registry
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 2,348
- Enrollment target
NCT01446965 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 2,348 participants.
The verdict
NCT01446965, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,348 participants
- Enrollment target
Study Summary
This study explores the hypothesis that wearable defibrillators can impact mortality by reducing sudden death during the first three months after a heart attack in persons with high risk for life-threatening arrhythmias.
Interventions
- DEVICE wearable defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,348 participants |
| Start Date | 2008-07 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01446965
The ClinicalTrials.gov registry entry for NCT01446965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,348 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which wearable defibrillator is the first listed.
NCT01446965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01446965 about?
NCT01446965 is a clinical study titled "Vest Prevention of Early Sudden Death Trial and VEST Registry". This study explores the hypothesis that wearable defibrillators can impact mortality by reducing sudden death during the first three months after a heart attack in persons with high risk for life-threatening arrhythmias.
What is the current status of trial NCT01446965?
This trial is currently completed. It is a NA study. The enrollment target is 2,348 participants. The study started on 2008-07. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT01446965?
The interventions under investigation include: wearable defibrillator (DEVICE).
Who is sponsoring clinical trial NCT01446965?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.